Enanta Pharmaceuticals Inc (ENTA) — Free Cash Flow Generation Index

Latest as of June 2025: 0.99x

Enanta Pharmaceuticals Inc (ENTA) has a Free Cash Flow Generation Index of 0.99x as of June 2025. Free cash flow of $17.35 Million represents 1% of operating cash flow ($17.51 Million). See ENTA working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.99x
Free Cash Flow / Operating CF

Free Cash Flow

$17.35 Million
USD

Operating Cash Flow

$17.51 Million
USD

Capital Expenditures

$155.00K
USD

Enanta Pharmaceuticals Inc Free Cash Flow Generation Index (2011–2020)

Historical FCF Generation Index trend for Enanta Pharmaceuticals Inc across 10 annual periods. Explore Enanta Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Enanta Pharmaceuticals Inc (2011–2020)

Year-by-year Free Cash Flow Generation Index for Enanta Pharmaceuticals Inc. For the full company profile including market capitalisation, see ENTA company net worth.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2020 0.80x $5.64 Million $7.09 Million $1.45 Million ▼ -13.9%
2019 0.92x $66.00 Million $71.42 Million $5.42 Million ▲ +2.9%
2018 0.90x $26.24 Million $29.22 Million $2.98 Million ▼ -5.7%
2017 0.95x $50.15 Million $52.65 Million $2.51 Million ▲ +9.8%
2016 0.87x $31.07 Million $35.81 Million $4.74 Million ▼ -10.5%
2015 0.97x $74.34 Million $76.67 Million $2.34 Million ▲ +2.2%
2014 0.95x $19.15 Million $20.18 Million $1.03 Million ▲ +0.6%
2013 0.94x $10.05 Million $10.65 Million $606.00K ▼ -4.6%
2012 0.99x $22.37 Million $22.62 Million $252.00K ▲ +0.8%
2011 0.98x $23.57 Million $24.02 Million $445.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).